G454 (Amphetamine and dextroamphetamine extended release 20 mg)
Pill imprint G454 has been identified as Amphetamine and dextroamphetamine extended release 20 mg.
Amphetamine/dextroamphetamine is used in the treatment of adhd; narcolepsy; fatigue and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Amphetamine/dextroamphetamine 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- G454
- Strength:
- 20 mg
- Color:
- Brown
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Impax Generics
More about amphetamine/dextroamphetamine
Consumer resources
- Amphetamine and dextroamphetamine
- Amphetamine and dextroamphetamine extended-release capsules
- Amphetamine/dextroamphetamine
- Amphetamine/dextroamphetamine extended-release capsules
- Dextroamphetamine and amphetamine (Advanced Reading)
- Other brands: Adderall, Adderall XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
